Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Resmi Charalel

Vascular & Interventional Radiology New York, NY Medical Doctor

NPI 1558653980 CMS profile 1388861

525 E 68Th St, Payson 512, New York, NY 10065

Open in the dashboard

General payments

$28,731

44 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$181,720 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Resmi Charalel of New York, NY is reported in the CMS Open Payments database as having received $28,731 across 44 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $181,720 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 87th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $14,208 17
2024 General $2,250 2
2023 General $11,860 20
2022 General $363 4
2021 General $50 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Resmi Charalel
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Resmi Charalel were reported at $14,208. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Resmi Charalel Vascular & Interventional Radiology median Middle half National median
2019 $0 $422 $125–$1,555 $163
2020 $0 $200 $68–$652 $114
2021 $50 $280 $99–$866 $132
2022 $363 $433 $137–$1,497 $149
2023 $11,860 $506 $152–$2,019 $160
2024 $2,250 $556 $175–$1,930 $164
2025 $14,208 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Siemens Medical Solutions USA, Inc. $6,830 4 payments
  2. Guerbet LLC $6,077 6 payments
  3. Surefire Medical, Inc. $5,584 15 payments
  4. Ge Healthcare $3,394 6 payments
  5. Embolx, Inc. $3,300 1 payment
  6. Instylla Inc. $2,984 6 payments
  7. Bard Peripheral Vascular, Inc. $203 2 payments
  8. Histosonics, Inc. $172 1 payment
  9. Galvanize Therapeutics, Inc $140 1 payment
  10. Sirtex Medical Inc $48 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $16,621 8 payments
  2. Travel and Lodging $5,713 13 payments
  3. Honoraria $3,000 1 payment
  4. Food and Beverage $2,695 19 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $600 2 payments
  6. Grant $101 1 payment
Products named General payments · program years 2021–2025
  1. TRINAV INFUSION SYSTEM $5,584 15 payments
  2. Cryocare CS $3,830 3 payments
  3. Instylla Delivery Kit Liquid Embolics for Interventional Radiology $2,175 2 payments
  4. INSTYLLA MICROCATHETER $2,125 1 payment
  5. Lipiodol $1,631 4 payments
  6. EMBRACE HYDROGEL EMBOLIC SYSTEM (HES) $787 3 payments
  7. INSTYLLA MICROCATHETER 1.2 $787 3 payments
  8. INSTYLLA DELIVERY KIT Vascular $787 3 payments
  9. Porter $190 1 payment
  10. ALIYA SYSTEM $140 1 payment
  11. Other $161 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 52 billing codes

Paid by Medicare

$17,443

Medicare's payments for the services billed

Medicare patients

55

Average age 72

Services billed

157

28 women, 27 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 55%
Chronic kidney disease 53%
Diabetes 51%
Heart failure 47%
Arthritis 44%
Atrial fibrillation 38%
Cancer 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

44 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record